BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6776666)

  • 1. Miconazole: an inhibitor of cyanide-insensitive respiration in Trypanosoma brucei.
    Opperdoes FR
    Trans R Soc Trop Med Hyg; 1980; 74(3):423-4. PubMed ID: 6776666
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of the mitochondrial cytochrome b-c1 complex inhibit the cyanide-insensitive respiration of Trypanosoma brucei.
    Turrens JF; Bickar D; Lehninger AL
    Mol Biochem Parasitol; 1986 Jun; 19(3):259-64. PubMed ID: 3016533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential use of inhibitors of glycerol-3-phosphate oxidase for chemotherapy of African trypanosomiasis.
    Opperdoes FR; Borst P; Fonck K
    FEBS Lett; 1976 Feb; 62(2):169-72. PubMed ID: 1253981
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative effects of salycylhydroxamic acid and glycerol on Trypanosoma brucei glycolysis in vitro and in vivo.
    Brohn FH; Clarkson AB
    Acta Trop; 1978 Mar; 35(1):23-33. PubMed ID: 24994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m-Chlorobenzhydroxyamic acid--an inhibitor of cyanide-insensitive respiration in Trypanosoma brucei.
    Evans DA; Brown RC
    J Protozool; 1973 Feb; 20(1):157-60. PubMed ID: 4347869
    [No Abstract]   [Full Text] [Related]  

  • 6. Trypanosoma brucei: host parasite interaction in parasite destruction by salicylhydroxamic acid and glycerol in mice.
    Amole BO; Clarkson AB
    Exp Parasitol; 1981 Feb; 51(1):133-40. PubMed ID: 6109641
    [No Abstract]   [Full Text] [Related]  

  • 7. Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate catabolism.
    Clarkson AB; Brohn FH
    Science; 1976 Oct; 194(4261):204-6. PubMed ID: 986688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei.
    Minagawa N; Yabu Y; Kita K; Nagai K; Ohta N; Meguro K; Sakajo S; Yoshimoto A
    Mol Biochem Parasitol; 1997 Feb; 84(2):271-80. PubMed ID: 9084049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma brucei brucei: a systematic screening for alternatives to the salicylhydroxamic acid-glycerol combination.
    Clarkson AB; Grady RW; Grossman SA; McCallum RJ; Brohn FH
    Mol Biochem Parasitol; 1981 Sep; 3(5):271-91. PubMed ID: 6795501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on Trypanosoma brucei differentiating bloodstream trypomastigotes and established procyclic trypomastigotes when grown in the presence of respiratory inhibitors.
    Le Febvre RB; Hill GC
    J Parasitol; 1986 Jun; 72(3):481-3. PubMed ID: 3018211
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycosyl phosphatidylinositols in Trypanosoma brucei.
    Raper J; Doering TL; Buxbaum LU; Englund PT
    Exp Parasitol; 1993 Mar; 76(2):216-20. PubMed ID: 8454032
    [No Abstract]   [Full Text] [Related]  

  • 12. Esters of 3,4-dihydroxybenzoic acid, highly effective inhibitors of the sn-glycerol-3-phosphate oxidase of Trypanosoma brucei brucei.
    Grady RW; Bienen EJ; Clarkson AB
    Mol Biochem Parasitol; 1986 Oct; 21(1):55-63. PubMed ID: 3773935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounds containing 2-substituted imidazole ring for treatment against human African trypanosomiasis.
    Samant BS; Sukhthankar MG
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1015-8. PubMed ID: 21211967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei.
    Minagawa N; Yabu Y; Kita K; Nagai K; Ohta N; Meguro K; Sakajo S; Yoshimoto A
    Mol Biochem Parasitol; 1996 Oct; 81(2):127-36. PubMed ID: 8898329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of tunicamycin against Trypanosoma brucei in vitro and in vivo.
    Casero RA; Porter CW; Bernacki RJ
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1008-11. PubMed ID: 7159066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DFMO: an alternative therapeutic agent for human African trypanosomiasis].
    Breton JC; Bouteille B; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):571-7. PubMed ID: 3143490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
    Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
    Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on difluoromethylornithine in African trypanosomes.
    McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
    Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo anti-Trypanosoma brucei activities of phenazinomycin and related compounds.
    Otoguro K; Ishiyama A; Iwatsuki M; Namatame M; Nishihara-Tukashima A; Nakashima T; Shibahara S; Kondo S; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Sep; 63(9):579-81. PubMed ID: 20588299
    [No Abstract]   [Full Text] [Related]  

  • 20. Trypanocidal activity of organotin chlorides on Trypanosoma brucei-infected mice.
    Shuaibu MN; Ameh DA; Bonire JJ; Adaudi AO; Ibrahim S; Nok AJ
    Parasite; 2000 Mar; 7(1):43-5. PubMed ID: 10743647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.